Drug Information Only – MOTS-c (Mitochondrial-Derived Peptide)

Name: Drug Information Only – MOTS-c (Mitochondrial-Derived Peptide)

category: Mitochondrial & Metabolic

description: THIS PAGE IS FOR INFORMATIONAL PURPOSES ONLY. THIS COMPOUND IS NOT SOLD ON THIS WEBSITE. MOTS-c is a mitochondrial-derived peptide encoded within the 12S rRNA gene of the mitochondrial genome. It is studied for roles in metabolic regulation, insulin sensitivity, and exercise capacity. Endogenous MOTS-c levels decline with age. Currently in early-phase human research. No BPOM, FDA, or EMA approval. FDA Category 2 restricted compounding substance.

composition: MOTS-c (mitochondrial-derived peptide) — NOT BPOM-registered

packaging: Not commercially available in Indonesia. This compound is not sold on this website.

how_to_use: Not applicable. Please book a consultation with a BaliDoc physician to discuss BPOM-registered alternatives appropriate for your condition.

side_effects: Drug use generally has certain side effects and depends on each individual. If excessive or dangerous side effects occur, please consult medical personnel. Human safety data is very limited; early-phase only.

Warning: THIS PRODUCT IS NOT FOR SALE. Not registered with BPOM. Cannot legally be prescribed or dispensed in Indonesia. This page exists solely to provide educational information. FDA Category 2 restricted.

Not applicable — this compound is not dispensed through BaliPharma.

Licensed alternatives available in Indonesia: For metabolic health and insulin sensitivity: Metformin (BPOM-registered, prescription required), CoQ10, Magnesium, and regular aerobic exercise protocols under physician guidance. Your BaliDoc physician can assess your metabolic markers and advise appropriately.

Prescription information: Prescription needed. Trusted by Bali locals, tourists, expats, and nomads, BaliPharma ensures safety and reliability with convenient delivery across Bali, plus free online doctor consultations at BaliDoc.com for added ease and support.